Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Bone Biologics Corp. (BBLG) had Normalized Income after Taxes of $-1.52M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-1.52M |
|
-- |
|
-- |
|
$1.55M |
|
$-1.55M |
|
$0.03M |
|
$-1.52M |
|
$-1.52M |
|
$-1.52M |
|
$-1.52M |
|
$-1.52M |
|
|
Normalized Income after Taxes |
$-1.52M |
$-1.55M |
|
$-1.55M |
|
1.52M |
|
1.52M |
|
$-0.48 |
|
$-0.48 |
|
| Balance Sheet Financials | |
$3.86M |
|
-- |
|
-- |
|
$3.86M |
|
$0.38M |
|
-- |
|
-- |
|
$0.38M |
|
$3.48M |
|
$3.48M |
|
$3.48M |
|
2.95M |
|
| Cash Flow Statement Financials | |
$-4.12M |
|
-- |
|
$4.42M |
|
$3.03M |
|
$3.33M |
|
$0.30M |
|
$0.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-43.68% |
|
-43.68% |
|
-39.41% |
|
-43.68% |
|
$1.18 |
|
$-2.72 |
|
$-2.72 |
|